RARE X CONFERENCE
Johannesburg, South Africa – 14-17 February, 2024
Report by: Roselyn Kanja-Odero, Global Gaucher Connect Leader – Africa Region
Introduction
I had the opportunity to attend the “Rare X Conference” held from 14-17 February 2024 at Indaba Hotel in Johannesburg, South Africa with the support of IGA. The conference brought together patients, clinicians, policymakers, academics, government, and pharmaceutical companies from around the world to discuss the plight of rare diseases and find collaborative ways to improve patients’ lives and treatment efforts.
Key Highlights
Central to the conference discussions was a focus on patient advocacy, education, policy reform, and improving equitable access to ensure be/er outcomes and support for individuals living with rare diseases.
While the common challenges related to rare diseases in the sub-Saharan African context were highlighted, it was recognized that addressing them requires collaborative efforts. These efforts encompass fostering global partnerships, improving medical education and capacity building, enhancing surveillance systems, and implementing policy initiatives. Key areas of focus also involve prenatal care, newborn screening, genetic counselling, and the active engagement of patient organisations and communities in awareness-raising activities. Another crucial takeaway was the necessity for sustained investment in research and innovation to meet unmet needs, alongside improving access to care for individuals affected by rare diseases.
After the conference, patient advocates were provided with capacity-building sessions that centered on developing advocacy plans, understanding policy while engaging policymakers, and fundraising strategies. Additionally, a presentation on caregiver fatigue was delivered, offering valuable insights.
Key Takeaways as a Gaucher Leader
- Networking Opportunities: Connections were made with key industry and laboratory technicians who could potentially support the Africa Roadmap Project.
- Advocacy Planning: Strategies for developing a regional advocacy plan were discussed, offering guidance on how to effectively advocate for important issues within the Gaucher community.
- Engaging Policy Makers: Sessions provided tips on engaging policymakers, including
seeking mentors, establishing strategic alliances, consulting local members before
speaking on their behalf, and emphasizing the importance of persistence in advocacy
efforts, given the cyclical nature of policymaking with election cycles.
Conclusion
Overall, the Rare Disease Conference provided valuable insights into the latest developments in the field of rare diseases in the region and beyond. It underscored the importance of collaboration, advocacy, and patient-centered care in addressing the unique challenges faced by individuals with rare diseases. The conference was a valuable opportunity to learn, connect, and contribute to the advancement of rare disease research and patient care.
